相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
C. Michael Gibson et al.
AMERICAN HEART JOURNAL (2011)
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Jeffrey L. Anderson et al.
CIRCULATION (2011)
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
Claes Held et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)
B. I. Eriksson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
John H. Alexander et al.
CIRCULATION (2009)
Treatment of Acute Myocardial Infarction in Patients with Stimulant ST-segment Elevation
Frans Van de Werf et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
Rikke Sorensen et al.
LANCET (2009)
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
J. L. Mega et al.
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
Frans Van de Werf et al.
EUROPEAN HEART JOURNAL (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety, tolerability, and initial efficacy of AZD6140, the first reversivle oral adenosine diphosphate receptor antagonist, compared with clopidigrel, in patients with non-ST-segment elevation acute coronary syndrome - Primary results of the DISPERSE-2 trial
Christopher P. Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery
B. I. Eriksson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European society of cardiology
Jean-Pierre Bassand et al.
EUROPEAN HEART JOURNAL (2007)
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
Keith A. A. Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
Pasi P. Karjalainen et al.
EUROPEAN HEART JOURNAL (2007)
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Keith A. A. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25 307 patients
F Andreotti et al.
EUROPEAN HEART JOURNAL (2006)
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: Meta-analysis with estimates of risk and benefit
MB Rothberg et al.
ANNALS OF INTERNAL MEDICINE (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
The pharmacology and management of the vitamin K antagonists
J Ansell et al.
CHEST (2004)
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes
ML Simoons et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Predictors of hospital mortality in the global registry of acute coronary events
CB Granger et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Oral ximelagatran for secondary prophylaxis after myocardial infarction:: the ESTEEM randomised controlled trial
L Wallentin et al.
LANCET (2003)
Warfarin, aspirin, or both after myocardial infarction.
M Hurlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a veterans affairs medical center
BC Bradley et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
分享论文
